Estimating the burden of smoking: Premature mortality, morbidity, and costs;Estimaciones de la carga debido al consumo de tabaco: Mortalidad, morbilidad prematura, y costo

Salud Publica de Mexico

Volumn 52, Issue SUPPL.2, 2010, Pages

  Samet, Jonathan M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Economic costs; Mexico; Morbidity; Mortality; Smoking; Tobacco use; United States

Indexed keywords

EID: 78751614668     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342010000800005     Document Type: Article

References (44)

1. Levin ML. The occurrence of lung cancer in man. Acta Un Intern Cancer. 1953;9:531-41.
2. Levin ML, Goldstein H, Gerhardt PR. Cancer and tobacco smoking. A preliminary report. Journal of the American Medical Association. 1950;143:336-8.
3. Doll R, Hill AB. Smoking and carcinoma of the lung. British Medical Journal. 1950;2(4681):739-48.
4. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of six hundred and eighty-four proved cases. Journal of the American Medical Association. 1950;143(4):329-36.
5. Miura M, Daynard RA, Samet JM. The role of litigation in tobacco control. Salud Publica Mex. 2006;48 (Supplement 1):S121-S36.
6. U.S. Department of Health and Human Services. The health consequences of smoking. A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
7. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control. 2004;13(4):388-95. PMCID: 1747946.
8. Warner KE, Hodgson TA, Carroll CE. Medical costs of smoking in the United States: estimates, their validity, and their implications. Tob Control. 1999;8(3):290-300.
9. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res. 2001;10(3):195-216.
10. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol. 1988;128(6):1185-97.
11. Rothman KJ. Causes. American Journal of Epidemiology. 1976;104(6):587-92.
12. Centers for Disease Control and Prevention. Smoking-attributable mortality, morbidity and economic costs (SAMMEC). Atlanta: U.S. Department of Health and Human Services; 2010 [updated 2010; cited March 8]; Available from: http://apps.nccd.cdc.gov/sammec/.
13. Thun MJ, Day-Lally C, Myers DG, Calle EE, Flanders WD, Zhu BP, et al. Trends in tobacco smoking and mortality from cigarette use in Cancer Prevention Studies I (1959-1965) and II (1982-1988). In: Burns DM, Garfinkel L, Samet JM, editors. Changes in Cigarette Related Disease Risks and Their Implication for Prevention and Control: Monograph 8. Bethesda, Maryland: U.S. Government Printing Office; 1997:305-82.
14. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 1992;339(8804):1268-78.
15. Peto R, Lopez AD, Boreham J, Thun M. Mortality from smoking in developed countries 1950-2000 (2nd edition: updated June 2006). 2006 [updated 2006; cited 2010 March 8]; Available from: http://www.ctsu.ox.ac.uk/~tobacco/.
16. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72(3):429-445. PMCID: 2486718.
17. World Health Organization. Quantifying the Burden of Disease from mortality and morbidity. Geneva: World Health Organization; 2010 [updated 2010; cited March 8]; Available from: http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/.
18. Barendregt JJ, Bonneux L, van der Maas PJ. The health care costs of smoking. New England Journal of Medicine. 1997;337(15):1052-7.
19. Johnson E, Dominici F, Griswold M, Zeger S. Disease cases and their medical costs attributable to smoking: an analysis of the national medical expenditure survey. Journal of Econometrics. 2003;112(1):135-51.
20. Miller LS, Zhang X, Rice DP, Max W. State estimates of total medical expenditures attributable to cigarette smoking, 1993. Public Health Rep. 1998;113(5):447-58. PMCID: 1308416.
21. Miller VP, Ernst C, Collin F. Smoking-attributable medical care costs in the USA. Social Science & Medicine. 1999;48:375-91.
22. Zeger SL, Wyant T, Miller LS, Samet JM, Gastwirth J. Statistical testimony on damages in Minnesota v. Tobacco Industry. Statistical science in the courtroom. New York: Springer-Verlag; 2000.
23. U.S. Department of Health and Human Services. A report of the Surgeon General in collaboration with the Pan American Health Organization: Smoking and Health in the Americas. Atlanta GA: U.S. DHHS, Public Health Service, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; DHHS Publication No. (CDC) 92-8419; 1992.
24. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362(9387):847-52.
25. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52.
26. Tapia-Conyer R, Olaiz G, Cravioto P. [Mortality and possible lost years of life due to tobacco consumption in Mexico]. Gac Med Mex. 1994;130(6):425-31.
27. Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, Barquera S, et al. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008;5(6):e125. PMCID: 2429945.
28. Reynales-Shigematsu LM, Rodriguez-Bolanos Rde L, Jimenez JA, Juarez-Marquez SA, Castro-Rios A, Hernandez-Avila M. [Health care costs attributable to tobacco consumption on a national level in the Mexican Social Security Institute]. Salud Publica Mex. 2006;48 Suppl 1:S48-64.
29. Samet JM, Wipfli HL. Globe still in grip of addiction. Nature. 2010;463(7284):1020-1.
30. Oliveira AF, Valente JG, Leite IC. The disease burden attributable to smoking in the state of Rio de Janeiro, Brazil in 2000. Clinics (Sao Paulo). 2008;63(2):215-22. PMCID: 2664213.
31. Ossip-Klein DJ, Fisher S, Diaz S, Quinones Z, Sierra E, Dozier A, et al. Tobacco use in six economically disadvantaged communities in the Dominican Republic. Nicotine Tob Res. 2008;10(5):851-60. PMCID: 2730378.
32. Kuri-Morales P, Alegre-Diaz J, Mata-Miranda Mdel P, Hernandez-Avila M. [Mortality attributable to tobacco use in Mexico]. Salud Publica Mex. 2002;44 Suppl 1:S29-33.
33. Correa PC, Barreto SM, Passos VM. Smoking-attributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: a prevalence-based study. BMC Public Health. 2009;9:206. PMCID: 2711948.
34. Rehm J, Gnam W, Popova S, Baliunas D, Brochu S, Fischer B, et al. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs. 2007;68(6):886-95.
35. Smoking-attributable mortality-Mexico, 1992. MMWR Morb Mortal Wkly Rep. 1995;44(19):372-3, 9-81.
36. Dietz VJ, Novotny TE, Rigau-Perez JG, Schultz JM. Smoking-attributable mortality, years of potential life lost, and direct health care costs for Puerto Rico, 1983. Bull Pan Am Health Organ. 1991;25(1):77-86.
37. Baliunas D, Patra J, Rehm J, Popova S, Kaiserman M, Taylor B. Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy. Chronic Dis Can. 2007;27(4):154-62.
38. Perez PV, Traveieso DH, Roche RGG, Gorbea MB, Perez TR, Fernadez SJV. Smoking-attributable mortality in Cuba. MEDICC Review. 2009;11(3):43-7.
39. Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226-8.
40. Rodu B, Cole P. Declining mortality from smoking in the United States. Nicotine Tob Res. 2007;9(7):781-4.
41. Single E, Robson L, Xie X, Rehm J. The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction. 1998;93(7):991-1006.
42. Reynales-Shigematsu LM, Juarez-Marquez SA, Valdes-Salgado R. [Costs of medical care attributable to tobacco consumption at the Mexican Institute of Social Security (IMSS), Morelos]. Salud Publica Mex. 2005;47(6):451-7.
43. Arredondo A, Parada I, Carrillo C. Financial consequences of changes in health care demands related to tobacco consumption in Mexico: information for policy makers. Health Policy. 2002;61(1):43-55.
44. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002;51(14):300-3.